City
Epaper

India’s coronary drug-eluting stents mkt to register 4% CAGR by 2033: Report

By IANS | Updated: January 23, 2024 15:55 IST

New Delhi, Jan 23 The coronary drug-eluting stents market in India is set to grow at a compound ...

Open in App

New Delhi, Jan 23 The coronary drug-eluting stents market in India is set to grow at a compound annual growth rate of 4 per cent between 2023 and 2033, according to a report on Tuesday.

This is driven by the growing incidence of coronary artery diseases, improved access to the latest treatment options, higher diagnosis rates, and technological advancements in the country.

Already known as the heart disease capital of the world, India is seeing a growing incidence of cardiovascular diseases, especially among young adults, owing to a poor lifestyle.

The report by GlobalData, a data and analytics company, showed that India’s coronary drug-eluting stent market accounted for approximately 25 per cent of the Asia-Pacific (APAC) market in 2023.

“Heart diseases in India are growing rapidly, and if this trend persists, the nation could soon record the highest number of deaths from heart diseases. To address this challenge, advances in treatment methods, such as improvements in imaging equipment, stent design, and implantation techniques, are needed,” said Kanchan Chauhan, Medical Devices Analyst at GlobalData, in a statement.

In December 2023, Terumo, a Japanese company, launched Ultimaster Nagomi stent in India, which distinguishes itself by featuring a bioresorbable polymer coating that gradually dissolves after facilitating effective drug delivery, consequently preventing restenosis.

In contrast to traditional drug-eluting stents that use durable polymers, which may cause long-term complications such as chronic inflammation, Terumo's approach minimises the risk of inflammatory responses, improving overall patient safety.

“India is making rapid progress with regards to cardiovascular treatment. With high class hospitals, the availability of cost-effective treatment options, and skilled cardiologists, the nation is already a favourite destination for medical tourism. With efforts being made to continuously develop and deploy advanced cardiology treatment, India is poised to become a global hub for top-notch cardiology treatment,” Chauhan said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalIndia-US ties strengthen as Foreign Secretary Vikram Misri meets FBI chief Kash Patel

CricketBabar Azam breaks Chris Gayle's record; becomes fastest to reach 12,000 T20 runs

InternationalArtemis II crew reaches 'halfway' mark in their return journey to Earth: NASA

Politics"High voter turnout signals anti-incumbency, Congress likely to win in Assam, Keralam, Puducherry": Rashid Alvi

InternationalCalifornia Shooting Update: Suspect Gunman Killed After Tulare County Sheriff’s Deputy Shot Dead In Porterville

Health Realted Stories

Health2,527 eateries inspected, 703 kg of food destroyed as Gujarat steps up paneer–analogue checks

HealthJayant Patil urges Maha govt to scrap DPT vaccine strain sale​

HealthHealth Tips: How to Increase Hemoglobin Levels With Simple Food Pairings

HealthAssam Rifles seizes smuggled haul of rare medicinal plant in Mizoram, apprehends three

HealthPakistan's current response to TB insufficient as cases continue to rise: Report